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Received February 6, 2015; accepted April 6, 2015AbstractBackground: Retama raetam (RR) fruit is used in traditional Saudi folk medicine as a hypoglycemic herb. However, the potential toxicity of RR
has not been fully investigated. The current study aimed to explore the potential acute and subacute toxicities of the methanolic extract of RR
fruit in male and female rats.
Methods: The extent of acute toxicity of RR was tested 14 days after a single oral dose was administered (250 mg/kg, 500 mg/kg, or 750 mg/kg).
Additionally, subacute toxicity was tested 28 days after an oral dose of 250 mg/kg/d, 500 mg/kg/d, or 750 mg/kg/d was administered for 4 weeks.
Results: Subsequent to variable dosage testing, oral LD50 of RR was found to be 1995 mg/kg in rats. Oral doses of 500 mg/kg and 750 mg/kg
significantly decreased body weight gain. Subacute administration (750 mg/kg) was associated with significant manifestations of toxicity.
Additionally, subacute administration of the extract at doses of 500 mg/kg or 750 mg/kg significantly elevated alanine transaminase and aspartate
transaminase activities. Hepatotoxicity of RR was confirmed with histopathological findings. Subacute administration of RR (500 mg/kg)
showed histopathological changes in the liver as indicated by degenerated hepatocytes and early fibrosis, while a dosage of 750 mg/kg showed
congested central vein and vascular degeneration. Moreover, subacute administration of the extract at doses of 250 mg/kg, 500 mg/kg, or
750 mg/kg showed histopathological alterations in rat kidney that ranged from mild interstitial congestion to tubular degeneration. The extract
showed positive result in the Ames test.
Conclusion: Repeated administration of methanolic extract of RR (250 mg/kg) has a low nephrotoxic subacute toxicity potential, while it might
have hepatotoxic, nephrotoxic, and mutagenic effects at higher doses.
Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Retamaraetam (RR), of the familyFabaceae, is endogenous to
the north and east Mediterranean regions and Sinai.1,2 RR con-
tains flavones,3 quinolizidine alkaloids, dipiperidine alkaloids,4
lupin alkaloids,5,6 polysaccharides,7 and essential oils.8Conflicts of interest: The authors declare that there are no conflicts of interest
related to the subject matter or materials discussed in this article.
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http://dx.doi.org/10.1016/j.jcma.2015.06.011
1726-4901/Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical AssTraditionally, RR has been used in folk remedies for diabetes9
and hypertension.10 It has been used as an abortifacient, anthel-
mintic, emetic, purgative, sedative, antiseptic, and an antipru-
ritic.11 Furthermore, RR is an effective grazing plant for sheep
and camels.12 Experimental evidence indicates that RRpossesses
antihypertensive,13 diuretic,9 lipid and body weight-lowering,10
antioxidant,14,15 antibacterial,16 antihyperglycemic,17 antibacte-
rial, antifungal, and cytotoxic effects.18
There are reports indicating the potential toxicity of RR.
Respiratory failure has been reported in a neonate after folk
treatment with RR extract.19 Camels that were overgrazed on
RR suffered shivering and other signs of toxicity.12 RR
aqueous extract showed potent insecticide activity againstociation. All rights reserved.
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of RR, there is a scarcity of information regarding its toxicity
profile. Therefore, the current study was designed to explore
the acute and subacute toxicity of the methanolic extract of the
fruit RR in rats.
2. Methods2.1. ChemicalsCyclophosphamide, ethidium bromide, histidine, and
methyl alcohol were purchased from Sigma-Aldrich Co. (St.
Louis, MO, USA). Salmonella typhimurium was obtained
from American Type Culture Collection (ATCC; strain num-
ber AT-2638 and AT-100; Rockville, MD, USA). Kits for
blood chemistry were obtained from Dimension RxL Max
Integrated Chemistry System (Siemens Healthcare Di-
agnostics Inc., Eschborn, Germany). Nicotinamide adenine
dinucleotide phosphate, sterile top agar, benzo(a)pyrene, rat
liver extract S9, and dimethyl sulfoxide were obtained from
Xenometrix AG (Allschwil, Switzerland).2.2. Collection and extraction of RRRetama raetam (Forssk.) subsp. gussonei (RR) fruit were
collected in April 2012 from Al-Hoferah, Saudi Arabia. The
plant was identified and confirmed by the taxonomists of the
King Abdulaziz University Herbarium, Jeddah, Saudi Arabia.
RR fruit was left to rest at room temperature, and powdered
fruit was extracted with methanol using IKA ULTRA-
TURRAX T25 digital (Janke and Kunkel, IKA Labor-
technik, Stauten, Germany). Subsequently, the methanol was
distilled off at 40C under reduced pressure and a dark yellow
residue was obtained.2.3. Standardization of the methanolic extractRR extract was standardized based on its alkaloidal content
using gas chromatographyemass spectrometry (GCeMS)
analysis (Shimadzu GC-MS quadrupole system; model 2010,
Nakagyo-ku, Kyoto, Japan). Helium was chosen as a carrier
gas with a flow rate of 2.0 mL/min and an injector temperature
of 240C. The oven temperature was programmed to rise from
80e240C at a rate of 10C/min. MS were taken at 70 eV,
with an ion source temp of 200C and an interface temp of
250C. Alkaloids were identified referring to retention time of
authentic samples and comparing fragmentation patterns of
sample compounds with those of NIST 147 library data of the
GC-MS system (Mass Spectral Library, HP, Palo Alto, CA,
USA). Fifteen alkaloids were detected as stated in Table 1.2.4. AnimalsMale and female Sprague-Dawley rats (150e200 g) were
obtained from the animal facility of King Fahd Medical
Research Center, King Abdulaziz University. The animals
were provided with a standard pellet diet and water ad libitum.They were kept at 25 ± 2C room temperature, 45e55%
relative humidity, and had a 12 hour dark/light cycle. Pro-
cedures involving animals and their care were approved by the
Bioethical Committee, King Abdulaziz University.2.5. Experimental protocolOral LD50 of the methanolic extract of RR was determined
in rats at the beginning of the study. Acute toxicity of the
methanolic extract was tested in male and female rats 14 days
after a single oral dose (at three dose levels; 250 mg/kg,
500 mg/kg, or 750 mg/kg). The subacute toxicity was tested in
male and female rats 28 days after repeated daily oral doses
for 4 weeks (at three dose levels; 250 mg/kg/d, 500 mg/kg/d,
or 750 mg/kg/d). The effect of the methanolic extract of RR on
the following parameters was assessed: mortality and gross
symptoms of toxicity, whole body weight, hematological and
blood chemistry values of rats, organ weights, and histopath-
ological examination of liver and kidney sections. The po-
tential mutagenic and genotoxic effects were also assessed
using Ames and Comet tests, respectively.2.6. Determination of LD50LD50 was estimated based on the use of the Spearman-
Karber method.212.7. Acute toxicity studyThis study was performed according to the Organization of
Economic Cooperation and Development.22 Sprague-Dawley
rats of both sexes (150e200 g) were divided into four
groups (IeIV) of 16 animals (8 males and 8 females) matched
for weight. All animals had free access to water and food
throughout the experiment. Groups IIeIV were administered
the methanolic extract of RR at single oral doses of 250 mg/
kg, 500 mg/kg, or 750 mg/kg, and Group I served as the
control, receiving distilled water at the same volume. The
general behavior of rats was continuously monitored during
the first 24 hours and then daily thereafter, for a total period of
14 days. Changes in the normal activity of rats were monitored
and the time at which signs of toxicity or death appeared was
documented. Changes in the whole body weights of the rats
were monitored.
At the end of the observation period, all surviving animals
were fasted overnight. Blood samples (2e3 mL) were
collected from the common carotid vein into heparinized and
dry nonheparinized centrifuge tubes. The heparinized blood
was used for hematological studies (hematocrit, hemoglobin,
white blood cells, and platelets), using a fully automated
analyzer (Beckman Coulter ACT 10 Hematology Blood
Analyzer, EKG Machines, New York, NY, USA). The serum
was separated from the nonheparinized blood and was assayed
for biochemical parameters, using Dimension RxL Max Inte-
grated Chemistry System (Siemens Healthcare Diagnostics
Inc.). After blood collection, animals were sacrificed with
cervical dislocation. Various tissues (kidneys, liver, heart,
Table 1
Gas chromatography-mass spectrometry analysis of the alkaloidal content of Retama raetam fruits.
Alkaloid tR Area % Formula [M
þ] m/z (rel. int) Similarity %
N-methylcytisine 11.15 6.13 C12H16N2O 204 (18) 160 (3), 146(5), 58 (100) 89
Cytisine 11.80 18.51 C11H14N2O 190 (54) 160 (27), 146 (100), 134 (27), 117 (12),
109 (20), 93 (10), 82 (20), 68 (10), 44 (52)
95
5,6-Didehydrolupanine 13.49 18.09 C15H22N2O 246 (30) 147 (15), 134 (18), 98 (100), 97 (54), 67 (10) 98
Argentamin 21.08 9.14 C15H20N2O2 260 (30) 160 (10), 146 (21), 133 (5), 114 (100), 106 (3),
96 (25), 70 (24), 41 (20)
85
m/z (rel. int) ¼ mass number/charge number (relative intensity); tR ¼ retention time.
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from the liver and kidney were removed and fixed in a 10%
solution of buffered formalin. Then, they were dehydrated in
ascending grades of ethyl alcohol, cleared in xylol, and
mounted in molten paraffin at 58e62ºC. Tissue slices of
0.5 mm thickness were cut and stained with hematoxylin and
eosin and evaluated for any structural changes under a light
microscope (Olympus BX-50 Olympus Corporation, Tokyo,
Japan). All sections were evaluated without prior knowledge
of the animal treatment groups.2.8. Subacute toxicity studyFour groups of 16 rats (8 males and 8 females) were used.
Groups IIeIV received the methanolic extract of RR at daily
doses of 250 mg/kg, 500 mg/kg, or 750 mg/kg, and Group I
served as the control receiving distilled water at the same
volume, for a period of 28 days. During the period of
administration, the animals were weighed and observed daily
to detect any signs of toxicity. After 28 days, all surviving
animals were investigated in the same way that was used in the
acute toxicity study. Heparinized blood was used for hema-
tological studies while the serum separated from the non-
heparinized blood was assayed for blood chemistry.
Additionally, various tissues (kidneys, liver, heart, lung, and
spleen) were dissected and weighed, and wet sections from the
liver and kidneys were examined histopathologically.2.9. Ames testAmes test was performed on Salmonella typhimurium (ATCC
strain number AT-2638 and TA-100) as previously described by
Ames et al.23 Briefly, Salmonella typhimurium was plated on
histidine-deficientmediacontaining themethanolicextractofRR
(0.1mg/mL and 1mg/mL) for 4 days. The extent of colony growthTable 2
Mortality and gross signs of acute and subacute toxicity of the methanolic extract
Group D/T Acute signs of toxicity
Control Male 0/8 None
Female 0/8 None
250 mg/kg RR Male 0/8 None
Female 0/8 None
500 mg/kg RR Male 1/8 None
Female 1/8 Hypoactivity
750 mg/kg RR Male 2/8 Hypoactivity, loss of appetite
Female 2/8 Hypoactivity, loss of appetite
D/T ¼ dead/total; RR ¼ Retama raetam.indicates potential mutagenicity compared to ethidium bromide-
containing media (positive control).2.10. Comet testComet assay was performed on rat mature sperm as pre-
viously described.24 Briefly, six male adult Sprague-Dawley
rats were treated with the methanolic extract of RR
(250 mg/kg, 500 mg/kg, or 750 mg/kg) for 24 hours. At the
conclusion of the experiment, the rats were euthanized and
sperm was immediately collected from the cauda epididymis
in a phosphate-buffered solution for comet assay. Cyclophos-
phamide (100 mg/kg) was used as a positive control genotoxic
agent.2.11. Statistical analysisData are presented as mean ± standard deviation. Statistical
analysis was performed using one-way analysis of variance
followed by application of Tukey-Kramer multiple compari-
sons tests. A p value ¼ 0.05 was used as the criterion for
significance. All statistical analyses were performed using
GraphPad InStat Software Version 4, and graphs were
sketched using GraphPad Prism Software Version 4 (GraphPad
Software Inc., La Jolla, CA, USA).
3. Results3.1. Determination of oral LD50 of the methanolic
extract of RR in ratsThe oral LD50 in rats was calculated mathematically ac-
cording to the Spearman-Karber method21 to be 1995 mg/kg.
Furthermore, the 95% confidence limits of LD50 were
1218e3265 mg/kg.of Retama raetam in male and female rats.





Male 1/8 Hypoactivity, mild hyperventilation
Female 2/8 Hypoactivity, hyperventilation
Male 2/8 Convulsion, dizziness, hyperventilation, syncope
Female 3/8 Convulsions, dizziness, hyperventilation, syncope
694 M.M. Algandaby / Journal of the Chinese Medical Association 78 (2015) 691e7013.2. Effect on mortality and gross symptoms of toxicityIn the acute toxicity study, oral administration of RR-
methanolic extract caused no noticeable changes in the gen-
eral behavior of male and female rats at 250 mg/kg, compared
with the control group (Table 2). Some female rats manifested
minor symptoms of toxicity including hypoactivity (at 500 mg/
kg and 750 mg/kg) and loss of appetite at 750 mg/kg of the
extract. A few male rats receiving the highest dose (750 mg/kg)
of the extract manifested hypoactivity and loss of appetite. No
deaths occurred in both sexes at the dose 250 mg/kg. However,
there was a dose-related increase in mortality rate at higher
doses; one male and one female rat died after the administra-
tion of 500 mg/kg. In addition, two male and two female rats
died after the administration of 750 mg/kg (Table 2).
Subacute administration of RR-methanolic extract caused a
dose-related mortality with the highest mortality in the
750 mg/kg group. There was no noticeable change in the
general behavior of male and female rats at 250 mg/kg,
compared with the control group (Table 2). The administration
of a subacute dose of 500 mg/kg caused only hypoactivity and
mild hyperventilation in male rats, while female rats man-
ifested more severe hyperventilation. Subacute administration
of the highest dose (750 mg/kg) caused marked changes in the
general behavior of rats of both sexes in the form of convul-
sions, hyperventilation, dizziness, and syncope. The mortality
rate was slightly higher than that in the acute toxicity study;
two male and three female rats died after the administration of
500 mg/kg. In addition, three rats of each sex died after the
administration of 750 mg/kg (Table 2).3.3. Effect on changes in body weightNo significant changes occurred in body weight, food
intake, or utilization of food in male and female rats treated
acutely with single oral doses of the methanolic extract
(250 mg/kg, 500 mg/kg, or 750 mg/kg). Both the control and
treated rats appeared healthy at the end and throughout the 14-
day period of the study (Table 3). However, there were sig-
nificant decreases in body weight gains of male rats treated
subacutely with repeated oral doses of 500 mg/kg and 750 mg/Table 3
Body weights of male and female rats in acute toxicity of a single oral dose of
the methanolic extract of Retama raetam.
Group Sex Body weight (g) Weight gain (%)
D 0 D 14
Control Male 193 ± 13.8 226 ± 18.2 17.2
Female 181 ± 7.15 210 ± 11.7 16.0
250 mg/kg RR Male 191 ± 6.40 231 ± 5.70 21.0
Female 186 ± 8.19 220 ± 8.47 18.3
500 mg/kg RR Male 193 ± 5.44 233 ± 8.02 19.6
Female 184 ± 7.64 217 ± 7.45 17.9
750 mg/kg RR Male 192 ± 11.0 228 ± 11.8 19.2
Female 183 ± 8.04 213 ± 9.47 16.9
Data are presented as mean ± standard deviation.
RR ¼ Retama raetam.kg, being 24.3% and 13.2%, respectively, as compared with
the control group figure of 50.8% (Table 4). Similarly, body
weight gains of female rats decreased significantly when
treated subacutely with repeated oral doses of 500 mg/kg and
750 mg/kg, being 21.9% and 14.3%, respectively, as compared
with the control group's 49.3% (Table 4).3.4. Effect on hematological valuesThe hematological parameters of hemoglobin concentra-
tion, hematocrit value, white blood cells, and platelets in the
treated rats did not differ significantly from those of the con-
trol group. All the values were within control limits after the
experimental periods of both the acute and subacute studies
(Table 5).3.5. Effect on blood chemistryAs shown in Tables 6 and 7, single oral doses of RR-
methanolic extract had no noticeable effect on blood chem-
istry values in both sexes of rats. No significant treatment-
related changes were detected in the levels of glucose, creat-
inine, proteins, bilirubin, lipids, and liver enzyme activities.
However, in the subacute toxicity study, the oral dose of
750 mg/kg significantly decreased blood glucose level by
19.4% in male rats and 20.1% in female rats, compared with
their respective controls (Tables 8 and 9). Additionally,
administration of the extract to male and female rats at
repeated oral doses of 500 mg/kg and 750 mg/kg caused sig-
nificant elevation of blood urea nitrogen (BUN) and creatinine
(markers of renal function), alanine transaminase (ALT), and
aspartate transaminase (AST) activities (markers of hepatic
function; Tables 8 and 9).3.6. Effect on organ weightsThe weights of organs such as liver, kidney, lung, heart, and
spleen in the treated rats of both sexes did not differ signifi-
cantly ( p < 0.05) from that of the control groups. All the
values were within the control limits after the experimental
period of both the acute and subacute studies (Table 10).Table 4
Body weights of male and female rats in subacute toxicity of the methanolic
extract of Retama raetam.
Group Sex Body weight (g) Weight gain (%)
D 0 D 28
Control Male 193 ± 15.5 291 ± 25.5 50.8
Female 199 ± 19.3 297 ± 35.5 49.3
250 mg/kg RR Male 193 ± 27.7 300 ± 13.2 55.1
Female 190 ± 17.7 285 ± 13.3 50.2
500 mg/kg RR Male 196 ± 18.4 243 ± 13.6* 24.3*
Female 192 ± 18.4 234 ± 23.7* 21.9*
750 mg/kg RR Male 191 ± 15.0 216 ± 11.8* 13.2*
Female 196 ± 27.3 224 ± 11.1* 14.3*
Data are presented as mean ± standard deviation.
*Significantly different from corresponding control value at p < 0.05.
RR ¼ Retama raetam.
Table 5
Hematological values of male and female rats in acute and subacute toxicity of the methanolic extract of Retama raetam.
Group Sex HGB (g%) HCT (%) WBC (103/mm3) Platelet (105/mm3)
Acute Subacute Acute Subacute Acute Subacute Acute Subacute
Control Male 15.0 ± 0.17 15.3 ± 0.22 39.9 ± 0.61 42.2 ± 1.08 4.76 ± 0.47 4.31 ± 0.41 9.13 ± 0.41 9.47 ± 0.37
Female 14.9 ± 0.32 14.2 ± 0.32 40.3 ± 0.71 41.9 ± 1.04 4.35 ± 0.32 4.15 ± 0.38 8.83 ± 0.25 9.16 ± 0.18
250 mg/kg RR Male 16.2 ± 0.42 14.4 ± 0.84 41.6 ± 0.71 43.3 ± 0.96 4.19 ± 0.38 4.35 ± 0.55 9.61 ± 0.12 9.38 ± 0.42
Female 14.5 ± 0.22 14.2 ± 0.32 42.5 ± 0.76 41.3 ± 0.76 4.12 ± 0.38 4.15 ± 0.45 9.16 ± 0.18 9.66 ± 0.25
500 mg/kg RR Male 15.3 ± 0.43 14.9 ± 0.52 40.4 ± 0.63 42.7 ± 0.94 4.25 ± 0.43 4.11 ± 0.48 9.44 ± 0.24 8.94 ± 0.34
Female 15.3 ± 0.39 15.2 ± 0.33 41.3 ± 0.66 43.3 ± 0.67 4.25 ± 0.34 4.35 ± 0.39 9.56 ± 0.17 8.41 ± 0.28
750 mg/kg RR Male 15.0 ± 0.33 14.3 ± 0.74 42.1 ± 0.56 42.1 ± 0.71 4.47 ± 0.37 5.19 ± 0.87 9.11 ± 0.39 9.21 ± 0.42
Female 14.5 ± 0.33 14.2 ± 0.34 42.4 ± 0.78 42.3 ± 0.71 4.17 ± 0.41 5.15 ± 0.55 9.26 ± 0.28 9.15 ± 0.30
Data are presented as mean ± standard deviation.
HCT ¼ hematocrit; HGB ¼ hemoglobin; RR ¼ Retama raetam; WBC ¼ white blood corpuscles.
Table 6
Blood chemistry values of male rats in acute toxicity of the methanolic extract of Retama raetam.
Parameter Control 250 mg/kg RR 500 mg/kg RR 750 mg/kg RR
Glucose (mg/dL) 136 ± 12.3 137 ± 5.50 140 ± 16.0 131 ± 32.8
BUN (mg/dL) 14.5 ± 7.82 12.7 ± 5.20 13.5 ± 2.66 12.0 ± 1.60
Creatinine (mg/dL) 0.38 ± 0.07 0.38 ± 0.07 0.42 ± 0.04 0.33 ± 0.04
Total protein (g/dL) 6.10 ± 0.52 6.40 ± 0.52 6.58 ± 0.46 6.50 ± 0.45
Albumin (g/dL) 1.33 ± 0.12 1.38 ± 0.12 1.42 ± 0.15 1.38 ± 0.10
Globulin (g/dL) 4.76 ± 0.44 4.98 ± 0.42 4.18 ± 0.38 5.10 ± 0.38
Total bilirubin (mg/dL) 0.12 ± 0.01 0.13 ± 0.03 0.12 ± 0.02 0.12 ± 0.05
Direct bilirubin (mg/dL) 0.017 ± 0.008 0.019 ± 0.001 0.020 ± 0.003 0.020 ± 0.002
LDH (IU/L) 525 ± 204 416 ± 151 546 ± 222 511 ± 159
Amylase (IU/L) 687 ± 94.3 688 ± 106 683 ± 54.8 725 ± 88.9
Cholesterol (mg/dL) 71.7 ± 21.7 67.3 ± 20.0 75.0 ± 15.0 75.7 ± 11.1
Triglycerides (mg/dL) 59.5 ± 24.3 57.1 ± 18.0 56.1 ± 10.0 51.0 ± 11.7
AST (U/L) 92.0 ± 7.80 85.2 ± 15.7 85.8 ± 11.5 101 ± 13.5
ALT (U/L) 37.7 ± 8.40 35.8 ± 08.35 34.4 ± 2.64 40.6 ± 10.0
ALP (U/L) 1.33 ± 0.10 1.38 ± 0.11 1.41 ± 0.14 1.37 ± 0.10
Data are presented as mean ± standard deviation.
ALP ¼ alkaline phosphatase; ALT ¼ alanine transaminase; AST ¼ aspartate transaminase; BUN ¼ blood urea nitrogen; LDH ¼ lactate dehydrogenase;
RR ¼ Retama raetam.
Table 7
Blood chemistry values of female rats in acute toxicity of a single oral dose of the methanolic extract of Retama raetam.
Parameter Control 250 mg/kg RR 500 mg/kg RR 750 mg/kg RR
Glucose (mg/dL) 141 ± 20.1 139 ± 7.70 143 ± 15.2 137 ± 55.5
BUN (mg/dL) 13.2 ± 7.82 11.9 ± 4.30 13.8 ± 3.14 12.7 ± 2.10
Creatinine (mg/dL) 0.35 ± 0.08 0.36 ± 0.03 0.41 ± 0.07 0.34 ± 0.08
Total protein (g/dL) 6.98 ± 0.61 7.20 ± 0.66 7.30 ± 0.74 7.30 ± 0.37
Albumin (g/dL) 1.42 ± 0.21 1.25 ± 0.17 1.39 ± 0.21 1.29 ± 0.30
Globulin (g/dL) 4.51 ± 0.46 4.24 ± 0.51 5.14 ± 0.46 5.11 ± 0.74
Total bilirubin (mg/dL) 0.16 ± 0.04 0.15 ± 0.01 0.17 ± 0.02 0.13 ± 0.08
Direct bilirubin (mg/dL) 0.019 ± 0.004 0.018 ± 0.001 0.022 ± 0.001 0.021 ± 0.007
LDH (IU/L) 497 ± 114 502 ± 95.4 512 ± 122 510 ± 117
Amylase (IU/L) 656 ± 87.5 633 ± 120 677 ± 54.8 738 ± 79.6
Cholesterol(mg/dL) 76.0 ± 11.8 72.5 ± 10.0 72.0 ± 19.0 69.9 ± 14.8
Triglycerides (mg/dL) 48.6 ± 11.4 51.1 ± 13.0 46.3 ± 9.00 45.8 ± 7.90
AST (U/L) 97.0 ± 7.10 93.2 ± 15.7 90.2 ± 12.7 98.5 ± 21.8
ALT (U/L) 35.8 ± 6.20 39.2 ± 15.1 32.5 ± 3.19 41.8 ± 11.2
ALP (U/L) 1.38 ± 0.20 1.35 ± 0.30 1.34 ± 0.12 1.34 ± 0.20
Data are presented as mean ± standard deviation.
ALP ¼ alkaline phosphatase; ALT ¼ alanine transaminase; AST ¼ aspartate transaminase; BUN ¼ blood urea nitrogen; LDH ¼ lactate dehydrogenase;
RR ¼ Retama raetam.
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Table 8
Blood chemistry values of male rats in subacute toxicity of repeated oral doses of the methanolic extract of Retama raetam.
Parameter Control 250 mg/kg RR 500 mg/kg RR 750 mg/kg RR
Glucose (mg/dL) 144 ± 27.1 140 ± 9.70 130 ± 18.7 116 ± 44.1*
BUN (mg/dL) 14.3 ± 2.21 21.6 ± 2.84 23.1 ± 2.16* 27.6 ± 2.16*
Creatinine (mg/dL) 0.40 ± 0.05 0.41 ± 0.03 0.57 ± 0.05* 0.64 ± 0.07*
Total protein (g/dL) 6.47 ± 0.26 6.60 ± 0.24 6.83 ± 0.32 6.80 ± 0.29
Albumin (g/dL) 1.45 ± 0.07 1.44 ± 0.08 1.50 ± 0.11 1.56 ± 0.08
Globulin (g/dL) 5.02 ± 0.22 5.16 ± 0.20 5.32 ± 0.25 5.25 ± 0.24
Total bilirubin (mg/dL) 0.18 ± 0.05 0.17 ± 0.01 0.20 ± 0.06 0.21 ± 0.03
Direct bilirubin (mg/dL) 0.02 ± 0.006 0.02 ± 0.005 0.02 ± 0.008 0.02 ± 0.007
LDH (IU/L) 587 ± 140 520 ± 117 426 ± 155 528 ± 152
Amylase (IU/L) 858 ± 54.4 913 ± 66.3 920 ± 93.5 882 ± 60.7
Cholesterol(mg/dL) 66.1 ± 7.20 64.1 ± 6.99 62.0 ± 8.80 69.0 ± 8.20
Triglycerides (mg/dL) 74.8 ± 19.0 70.3 ± 10.9 84.6 ± 28.6 90.0 ± 30.9
AST (U/L) 104 ± 11.2 108 ± 16.9 190* ± 13.1 166* ± 38.3
ALT (U/L) 44.1 ± 6.50 58.7 ± 9.10 69.3* ± 7.90 71.5* ± 15.4
ALP (U/L) 1.45 ± 0.07 1.44 ± 0.08 1.50 ± 0.11 1.56 ± 0.08
Data are presented as mean ± standard deviation.
* Significantly different from corresponding control value at p < 0.05.
ALP ¼ alkaline phosphatase; ALT ¼ alanine transaminase; AST ¼ aspartate transaminase; BUN ¼ blood urea nitrogen; LDH ¼ lactate dehydrogenase;
RR ¼ Retama raetam.
Table 10
Organ weights of male and female rats in acute and subacute toxicity of the methanolic extract of Retama raetam.
Group Sex Organ weight (g/100 g body weight)
Liver Kidney Lung Heart Spleen
Acute Subacute Acute Subacute Acute Subacute Acute Subacute Acute Subacute
Control Male 3.18 ± 0.16 3.21 ± 0.13 0.43 ± 0.03 0.46 ± 0.07 0.49 ± 0.02 0.44 ± 0.01 0.41 ± 0.01 0.39 ± 0.01 0.25 ± 0.01 0.26 ± 0.04
Female 3.33 ± 0.31 2.97 ± 0.17 0.47 ± 0.08 0.44 ± 0.09 0.52 ± 0.05 0.41 ± 0.02 0.44 ± 0.04 0.41 ± 0.05 0.23 ± 0.02 0.22 ± 0.03
250 mg/kg RR Male 2.97 ± 0.02 3.38 ± 0.01 0.45 ± 0.02 0.47 ± 0.02 0.51 ± 0.03 0.42 ± 0.01 0.43 ± 0.01 0.38 ± 0.04 0.26 ± 0.01 0.28 ± 0.01
Female 3.15 ± 0.15 3.24 ± 0.19 0.41 ± 0.05 0.42 ± 0.07 0.49 ± 0.01 0.47 ± 0.05 0.47 ± 0.03 0.37 ± 0.07 0.29 ± 0.01 0.25 ± 0.05
500 mg/kg RR Male 3.21 ± 0.01 3.41 ± 0.01 0.41 ± 0.02 0.42 ± 0.01 0.46 ± 0.02 0.36 ± 0.01 0.38 ± 0.01 0.37 ± 0.01 0.28 ± 0.01 0.24 ± 0.02
Female 3.09 ± 0.07 3.37 ± 0.08 0.44 ± 0.07 0.47 ± 0.02 0.49 ± 0.05 0.39 ± 0.04 0.41 ± 0.03 0.42 ± 0.03 0.26 ± 0.09 0.21 ± 0.04
750 mg/kg RR Male 3.01 ± 0.20 3.56 ± 0.20 0.42 ± 0.01 0.45 ± 0.02 0.47 ± 0.03 0.45 ± 0.02 0.39 ± 0.02 0.39 ± 0.03 0.25 ± 0.01 0.27 ± 0.01
Female 3.58 ± 0.17 3.45 ± 0.23 0.43 ± 0.03 0.43 ± 0.07 0.45 ± 0.04 0.38 ± 0.05 0.43 ± 0.04 0.41 ± 0.01 0.27 ± 0.04 0.28 ± 0.03
Data are presented as mean ± standard deviation.
RR ¼ Retama raetam.
Table 9
Blood chemistry values of female rats in subacute toxicity of repeated oral doses of the methanolic extract of Retama raetam.
Parameter Control 250 mg/kg RR 500 mg/kg RR 750 mg/kg RR
Glucose (mg/dL) 150 ± 26.1 143 ± 15.6 138 ± 10.6 119* ± 20.8
BUN (mg/dL) 16.5 ± 2.42 19.8 ± 3.54 20.5* ± 3.19 27.6* ± 3.78
Creatinine (mg/dL) 0.40 ± 0.12 0.49 ± 0.08 0.71* ± 0.08 0.75* ± 0.03
Total protein (g/dL) 7.12 ± 0.31 6.90 ± 0.42 7.21 ± 0.49 7.11 ± 0.31
Albumin (g/dL) 1.51 ± 0.09 1.48 ± 0.06 1.52 ± 0.20 1.49 ± 0.05
Globulin (g/dL) 5.12 ± 0.45 5.09 ± 0.30 5.29 ± 0.27 5.22 ± 0.19
Total bilirubin (mg/dL) 0.18 ± 0.08 0.17 ± 0.02 0.19 ± 0.03 0.22 ± 0.04
Direct bilirubin (mg/dL) 0.02 ± 0.005 0.02 ± 0.012 0.02 ± 0.009 0.02 ± 0.005
LDH (IU/L) 540 ± 119 534 ± 154 522 ± 111 578 ± 142
Amylase (IU/L) 921 ± 44.6 989 ± 47.5 890 ± 95.7 897 ± 32.8
Cholesterol(mg/dL) 78.2 ± 5.40 72.8 ± 6.97 69.7 ± 8.10 70.4 ± 6.90
Triglycerides (mg/dL) 79.2 ± 13.0 72.8 ± 13.9 81.2 ± 18.9 95.7 ± 20.9
AST (U/L) 101 ± 13.2 105 ± 16.9 138 ± 13.1* 171 ± 14.8*
ALT (U/L) 46.1 ± 9.50 57.7 ± 11.1 61.3 ± 17.1* 77.5 ± 14.1*
ALP (U/L) 1.39 ± 0.04 1.47 ± 0.05 1.51 ± 0.13 1.52 ± 0.04
Data are presented as mean ± standard deviation.
*Significantly different from corresponding control value at p < 0.05.
ALT ¼ alanine transaminase; ALP ¼ alkaline phosphatase; AST ¼ aspartate transaminase; BUN ¼ blood urea nitrogen; LDH ¼ lactate dehydrogenase;
RR ¼ Retama raetam.
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Fig. 1. Effect of subacute toxicity of Retama raetam (RR) methanolic extract on histopathology of rat liver. Histopathological examination of liver sections of: (A)
control rats [hematoxylin and eosin stain (H&E)]; (B) rats treated with the methanolic extract of RR (250 mg/kg/d for 4 weeks) showing normal parenchymal cells,
portal system, and blood sinusoids (H&E); (C) rats treated with the methanolic extract of RR (500 mg/kg/d for 4 weeks) showing congested dilated central vein
with degenerated hepatocytes and early fibrosis (proliferated fibroblasts; H&E); and (D) rats treated with the methanolic extract of RR (750 mg/kg/d for 4 weeks)
showing congested central vein and dilated congested blood sinusoids in addition to vascular degeneration (H&E).
697M.M. Algandaby / Journal of the Chinese Medical Association 78 (2015) 691e7013.7. Histopathological examination of liver and kidneyIn the acute toxicity study, histopathological examinations
of liver sections were normal for all doses (250 mg/kg,
500 mg/kg, and 750 mg/kg). Similarly, liver sections from rats
treated with subacute dose of 250 mg/kg did not show any
histopathological changes (Fig. 1B). However, liver sections
from rats treated subacutely at 500 mg/kg of the extract
showed moderate changes such as congested dilated central
vein and blood sinusoids with degenerated hepatocytes and
early fibrosis (Fig. 1C). In addition, liver sections from rats
treated with a subacute dose (750 mg/kg) of the extract
showed severe changes such as vascular degeneration
(Fig. 1D).
In the acute toxicity study, histopathological examination of
kidney sections were normal at all tested doses (250 mg/kg,
500 mg/kg, and 750 mg/kg). In the subacute toxicity study,
however, examination of kidney sections showed dose-relatedhistopathological changes. Kidney sections from rats treated
subacutely with 250 mg/kg of the extract showed mild inter-
stitial congestion (Fig. 2B). Sections from rats treated sub-
acutely with 500 mg/kg showed moderate changes in the form
of early tubular degeneration in addition to interstitial
congestion (Fig. 2C). However, histopathological examination
of kidney sections from rats treated subacutely with the
highest dose of the extract (750 mg/kg) showed severe changes
such as congested glomeruli, wide Bowman's capsule, red cell
casts, and tubular degeneration (Fig. 2D).3.8. Ames testThe methanolic extract of RR showed a potential muta-
genic effect on Salmonella typhimurium (both strains AT-2638
and AT-100) manifested as significant growth of colonies
plated on 1 mg/mL extract-containing medium and mild
growth at 0.1 mg/mL extract-containing medium (Fig. 3).
Fig. 2. Effect of subacute toxicity of Retama raetam (RR) methanolic extract on histopathology of rat kidneys. Histopathological examination of kidney sections
of: (A) control rats [hematoxylin and eosin stain (H&E)]; (B) rats treated with the methanolic extract of RR (250 mg/kg/d for 4 weeks), showing mild interstitial
congestion (H&E); (C) rats treated with the methanolic extract of RR (500 mg/kg/d for 4 weeks), showing early tubular degeneration and interstitial congestion
(H&E); and (D) rats treated with the methanolic extract of RR (750 mg/kg/d for 4 weeks), showing congested engorged glomeruli, wide bowman capsule, some red
cell casts, and tubular degeneration (H&E).
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nuclei after treatment with the methanolic extract of RR up to
doses of 750 mg/kg (Fig. 4).
4. Discussion
In Saudi folk medicine, fruit of RR is used in remedies for
diabetes.12 AWorld Health Organization survey indicated that
~70e80% of the global population depends on alternative
medicine, predominantly herbal in nature, in their primary
health care. This is especially the case in developing countries
where the cost of consulting a Western-style physician and the
cost of medicines are not affordable for the large majority of
the population.25,26 Although medicinal plants may produce
several biological activities in humans, generally very little is
known about their toxicity and the same applies for RR.
Therefore, the aim of the present study was to evaluate theacute and subacute toxicity of the methanolic extract of RR in
male and female rats.
In an attempt to evaluate the safety margin of methanolic
extract of RR in healthy rats, oral LD50 was determined ac-
cording to the Spearman-Karber method.21 Oral LD50 was
calculated to be 1995 mg/kg, at 95% confidence limits of
1218e3265 mg/kg. This dose was approximately from four to
eight times the tested concentrations for antidiabetic activity,17
indicating a relatively limited methanolic extract of RR safety
margin. In addition, the classification of Loomis and Hayes27
indicated that substances with LD50 between 500 mg/kg
bodyweight and 5000 mg/kg bodyweight and between
5000 mg/kg bodyweight and 15,000 mg/kg bodyweight are
regarded as being slightly toxic and practically nontoxic,
respectively. Therefore, the present results suggest that the
safety level of RR-methanolic extract falls within the first
category, being slightly toxic.
In order to investigate the effect of the methanolic extract
of RR fruit on mortality and gross symptoms of toxicity,
Fig. 3. Ames test for Retama raetam (RR) methanolic extract. Ames test for: (A) negative control; (B) positive control (ethidium bromide), showing growth of
Salmonella typhimurium on histidine-deficient medium in the presence of ethidium bromide; (C) methanolic extract of RR (0.1 mg/mL), showing mild growth of
Salmonella typhimurium on histidine-deficient medium; and (D) methanolic extract of RR (1.0 mg/mL), showing significant growth of Salmonella typhimurium on
histidine-deficient medium.
Fig. 4. Comet test for negative control (A) the methanolic extract of Retama raetam; (B) 750 mg/kg showing no DNA aberration; and (C) positive control
(cyclophosphamide), showing significant DNA aberration.
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kg, and 750 mg/kg) were tested in male and female rats in both
an acute and subacute manner. In both studies, oral adminis-
tration of RR methanolic extract caused neither noticeable
change in the general behavior nor death in both sexes at thesmallest dose. However, there was a dose-related increase in
symptoms of toxicity and mortality rate at the higher doses.
These findings could be explained by the relatively low safety
margin of this methanolic extract, as classified by Loomis and
Hayes.27
700 M.M. Algandaby / Journal of the Chinese Medical Association 78 (2015) 691e701In the acute toxicity study, RR-methanolic extract, regard-
less of dose used, neither appeared to affect the body weight of
the rats of both sexes, nor did it cause significant changes in
their food intake or utilization of food. However, there were
significant decreases in body weight gains of male and female
rats when treated subacutely with repeated oral doses of
500 mg/kg and 750 mg/kg. This suggests that, at these oral
doses, the extract could retard the growth of rats of both sexes.
In both acute and subacute studies, there were no treatment-
related changes in the hematological parameters in rats of
both sexes (i.e., hematocrit value, hemoglobin concentration,
platelets, and white blood cells). This indicates that the RR-
methanolic extract did not interfere with the production of
platelets. Hematopoiesis and leucopoiesis also were not
affected even though the hematopoietic system is one of the
most sensitive targets for toxic compounds,28 as well as an
important marker of physiological and pathological status in
man and animals.29 In addition, many of the biochemical pa-
rameters (i.e., serum proteins, lipids, bilirubin, amylase, and
lactate dehydrogenase) were also unchanged in both sexes of
rats by the ingested RR-methanolic extract, regardless of the
dose given either in acute or subacute studies.
Concerning blood glucose level, it was significantly
decreased in rats of both sexes at the subacute dose of 750 mg/
kg. This might reflect the pharmacological hypoglycemic ef-
fect of RR-methanolic extract9,30 that was ascribed, at least
partly, to stimulating pancreatic insulin release and reducing
intestinal glucose absorption.17
There were slight but significant elevations in the levels of
ALT and AST at subacute doses of 500 mg/kg and 750 mg/kg
in both male and female rats. These findings suggest that
subacute ingestion of RR-methanolic extract at relatively high
doses is hepatotoxic in rats. The transaminases (AST and ALT)
are biomarker enzymes used to predict possible toxicity.31
Generally, damage to the parenchymal liver cells results in
elevation of both transaminases.32 Interestingly, the elevation
of AST level was about twice the increase in ALT. The iso-
lated elevation of AST levels, in the presence of normal levels
of other cholestatic markers, could be justified apart from liver
injury. AST is present in different tissues (including heart,
skeletal muscle, kidney, brain, and liver) while ALT is local-
ized primarily in the liver. Moreover, AST can exist as a
complex with an immunoglobulin, and this macromolecule
can cause an elevation in serum AST activity, which may be
detected in blood chemistry analysis and mistakenly be
considered to highlight the occurrence of liver dysfunction.33
Thus, RR might influence previous mechanisms that cause
more elevations of the AST than ALT levels, rather than acting
on the liver.
BUN and creatinine levels were significantly elevated at
subacute doses of 500 mg/kg and 750 mg/kg in both male and
female rats. These findings suggest that subacute ingestion of
RR-methanolic extract at relatively high doses is nephrotoxic
in rats. This is in contrast with previous studies that suggested
the ability of the methanolic extract of the powder of the dried
seeds of RR to protect against gentamicin-induced nephro-
toxicity34 and cadmium chloride-induced hepato- and nephro-toxicities15 in rats. The apparent differences can be explained
on the basis of the differences in method of extraction, the
dosing regimen, as well as the differences in the part used, and
environment of RR which might affect the presence and/or
concentration of the active constituents. The hepatoxic and
nephrotoxic effects of RR-methanolic extract require further
investigation.
The weights of organs (liver, kidney, lung, heart, and
spleen) in the treated male and female rats did not differ
significantly from those of the control group, in both the acute
and subacute studies. Therefore, it was necessary to examine
liver and kidney tissues histopathologically, in order to detect
any microscopic changes that might be present. Examination
of liver and kidney sections taken from rats exposed to single
oral doses of RR methanolic extract failed to show any his-
topathological changes, which comply with the normal pattern
of biochemical parameters, as previously observed in the acute
study. However, histopathological examination of liver sec-
tions from rats treated with subacute doses (500 mg/kg and
750 mg/kg) of the extract showed significant dose-related
changes. These findings could explain the previously
mentioned elevation in the transaminases (ALT and AST)
levels. In a similar pattern, histopathological examination of
kidney sections from rats treated subacutely with 250 mg/kg
showed only minimal changes, which gradually became more
evident at subacute doses of 500 mg/kg and 750 mg/kg of the
extract. Thus, the significant elevation of BUN and crea-
tininedas observed previouslydis confirmed by these histo-
pathological findings.
In order to investigate the potential mutagenicity and gen-
otoxicity of the methanolic extract of RR, both Ames and
Comet tests were conducted. In the Ames test, the extract was
shown to have a potential mutagenic effect, manifested by
evident growth of colonies plated on 1.0 mg/mL extract-
containing medium and minimal growth at 0.1 mg/mL
extract-containing medium. These data are contradictory to the
findings of Alkofahi and Al-Khalil35 who indicated that aerial
parts of RR did not show any observable mutagenic activity.
This discrepancy may be due to differences in the part used as
we examined RR fruit. However, use of the Comet test failed
to detect any DNA aberrations in rat sperm nuclei after
treatment with the methanolic extract of RR up to doses of
750 mg/kg.
In conclusion, the current study provided valuable data on
the acute and subacute toxicity of the methanolic extract of
RR. The extract appeared to be slightly toxic (with a relatively
low LD50), but caused no apparent organ damage. Under our
experimental conditions, RR methanolic extract can exhibit
hepatotoxic and nephrotoxic effects at moderate to high sub-
acute doses. In addition, it could be potentially mutagenic,
based on experimental studies. Further toxicity studiesdto
investigate its potential subchronic, chronic, developmental,
reproductive, and carcinogenic effectsdare needed to com-
plete the safety profile of RR. Collectively, the findings of the
present study suggest a low subacute toxicity potential for RR,
and in high doses might have hepatotoxic, nephrotoxic, and
mutagenic effects.
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